Targeting the endocannabinoid system with microbial interventions to improve gut integrity

Area of Science:

• Gastroenterology
• Microbiology
• Metabolism

Background:

• The endocannabinoid system (ECS) is a key metabolic pathway mediating host-gut microbiota communication.
• ECS in the gut regulates intestinal barrier integrity, crucial for preventing inflammation.
• Compromised gut barrier integrity is linked to inflammatory bowel disorder, obesity, and major depressive disorder.

Purpose of the Study:

• To review the role of the ECS in maintaining gut barrier integrity.
• To discuss the implications of ECS dysregulation in gut-related disorders.
• To highlight the potential of targeted microbial interventions for ECS modulation.

Main Methods:

• Literature review of studies on the endocannabinoid system and gut health.
• Analysis of the relationship between ECS activity and intestinal barrier function.
• Examination of current microbial interventions, including probiotics.

Main Results:

• ECS activity is altered in gut disorders, increasing in obesity and decreasing in inflammatory bowel disease.
• Impaired gut barrier integrity allows bacterial metabolite translocation, leading to inflammation.
• Targeting the ECS offers a potential therapeutic strategy for gut barrier restoration.

Conclusions:

• The ECS plays a critical role in gut barrier homeostasis.
• The ambiguous role of ECS in different gut conditions necessitates personalized therapeutic approaches.
• Developing targeted microbial interventions for the ECS is a promising avenue for treating gut barrier dysfunction.